Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial (Q34466433)

2 August 2017

Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial (English)

1 reference

non-alcoholic steatohepatitis

2 August 2017

0 references

0 references

1 reference

Kotacherry T Shenoy

1

1 reference

2 August 2017

Leena K Balakumaran

2

1 reference

2 August 2017

Philip Mathew

3

1 reference

2 August 2017

Mohan Prasad

4

1 reference

2 August 2017

Boddu Prabhakar

5

1 reference

2 August 2017

Ajit Sood

6

1 reference

2 August 2017

Shivaram P Singh

7

1 reference

2 August 2017

Nagaraj P Rao

8

1 reference

2 August 2017

Shoukat A Zargar

9

1 reference

2 August 2017

Angelo A Bignamini

10

1 reference

2 August 2017

27 March 2014

1 reference

Journal of clinical and experimental hepatology

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

2

1 reference

2 August 2017

94-100

1 reference

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Metadoxine in the Treatment of Acute and Chronic Alcoholism: A Review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Metadoxyl in combined treatment of alcohol damage to the liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Clinical, biochemical and histological profile of nonalcoholic steatohepatitis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Long-term ethanol administration enhances age-dependent modulation of redox state in central and peripheral organs of rat: protection by metadoxine.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116708

Nonalcoholic steatohepatitis: clinicopathological profile

27 October 2018

1 reference

12 December 2020

Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats

1 reference

12 December 2020

Changes in Expression of the Albumin, Fibronectin and Type I Procollagen Genes in CCl4-Induced Liver Fibrosis: Effect of Pyridoxol L,2-Pyrrolidon-5 Carboxylate

1 reference

12 December 2020

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats

1 reference

12 December 2020

Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes

1 reference

12 December 2020

[Metadoxine in the control of oxidative stress caused by acute and chronic ethanol poisoning]

1 reference

12 December 2020

Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats

1 reference

12 December 2020

Nonalcoholic fatty liver disease in the Indian subcontinent: a medical consequence of globalization?

1 reference

12 December 2020

Pyridoxol ,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl-treated rats

1 reference

12 December 2020

10.1016/J.JCEH.2014.03.041

Identifiers

DOI

1 reference

release_qtlmvsfdabedpmeaz2omi35z3e

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qtlmvsfdabedpmeaz2omi35z3e

24 November 2022

mapped directly with Wikidata item

PMCID

4116708

1 reference

2 August 2017

1 reference